126129-41-7

Upstream product

• 371-14-2 4-fluorophenylhydrazine 
• 615-79-2 ethyl 2,4-diketopentanoate 
• 823-85-8 4-fluorophenyhydrazine hydrochloride 

Downstream Products

• 288251-66-1 1-(4-fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid 
• 943863-65-8 [1-(4-fluorophenyl)-5-methyl-1H-pyrazol-3-yl]methanol 

Relevant academic research and scientific papers

PYRAZOLOALKYL SUBSTITUTED IMIDAZO RING COMPOUNDS AND METHODS

Imidazo ring compounds, (e.g., imidazo[4,5-c]quinoline, 6,7,8,9-tetrahydro imidazo[4,5-c]quinoline, imidazo[4,5-c]naphthyridine, 6,7,8,9-tetrahydro imidazo[4,5-c]naphthyridine and imidazo[4,5-c]pyridine compounds) having a pyrazoloalkyl substituent at the

AMIDE COMPOUNDS AND MEDICINAL USE THEREOF

The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X' is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.